Genomic Health (GHDX)

34.56 +0.30  +0.88%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart GHDX Price Chart

Key Stats

Market Cap 1.036B
Revenue Growth 17.38%
Profit Margin 1.33%
Earnings Yield 0.84%
Dividend Yield 0.00%
Earnings Per Share TTM 0.29
PE Ratio 119.17
Price / Sales Ratio 4.826
52 Week High 35.00
52 Week Low 19.00
Beta 0.5261
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 24 NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY by chessNwine
May 23 $GHDX Insider Buy: $5.4M of stock bought by Felix Baker between May 21, 2012 - May 22, 2012 http://stks.co/3xjR by MarketBrief
May 22 Beating the Blues: Darden Restaurants and Genomic Health Fool
May 21 Excellent Science + Unmet Need Equal Great Returns Fool
May 18 Myriad Reiterated Neutral
May 17 Insiders Trading VRX, RAX, GHDX
May 16 $GHDX Insider Buy: $12.7M of stock bought by Felix Baker between May 14, 2012 - May 16, 2012 http://stks.co/3rdD by MarketBrief
May 16 Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Br...
May 16 3 Stocks Near 52-Week Highs Worth Selling Fool
May 16 $GHDX New 52 Week High - Crossed daily highs resistance. by TradeIdeasQuant
May 15 $GHDX New 52 Week High - Crossed daily highs resistance. by TradeIdeasQuant

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Medical Laboratories & Research

Genomic Health, Inc. is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. The company was founded by Patrick Terry in August 2000 and is headquartered in Redwood City, California.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Genomic Health is up 35.00% over the last year vs S&P 500 Total Return up 2.57%, Life Technologies Corporation down 19.83%, and Bio - Reference Laboratories down 10.17%.

  • GHDX Total Returns
  • ^SPXTR Total Returns
  • LIFE Total Returns
  • BRLI Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring GHDX

Did Genomic Health make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

GHDX Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
GHDX 34.56 +0.30 +0.88% 1.027B
GGP 16.81 -0.17 -1.00%
GGC 30.86 -0.17 -0.55% 1.024B
GG 37.70 +0.26 +0.69% 30.37B
GFI 13.29 +0.14 +1.06% 9.629B
GEOY 20.39 +1.29 +6.75% 432.12M
GEO 21.98 +0.07 +0.32% 1.368B
GE 19.20 -0.05 -0.26% 202.95B
GDXJ 20.03 +0.53 +2.72%
GDX 44.91 +0.28 +0.63%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close